Skip to main content

People In The News: Mar 26, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Frank Pitzer has been named CEO of Roche NimbleGen. Pitzer has been with Roche for more than eight years, most recently as head of divisional quality and regulatory affairs at Roche Diagnostics.

"Frank's leadership skills and extensive experience in the life science industry make him the perfect fit to guide Roche NimbleGen through the next stages of growth," Manfred Baier, head of Roche Applied Science, said in a statement. "His valuable insight and outstanding management experience will further entrench the company as a leading manufacturer of microarray technologies."

Bio-Rad Laboratories has appointed Ted Love to serve on its board of directors and on the board's audit committee. The move enabled the company to regain compliance with regulations of the New York Stock Exchange, which requires that a listed company have three independent directors on its audit committee. Love currently is executive VP of R&D at Onyx Pharmaceuticals, and from 2001 to 2009 he was president and CEO of Nuvelo. Love also previously spent six years in senior management at Genentech.

NanoString has tapped William Young to be executive chairman of its board of directors. Young formerly was CEO and chairman of Monogram Biosciences and he was COO at Genentech. He currently serves as chairman of the board of directors of Biogen, is chairman emeritus for BayBio, and he is a director at Theravance.

Complete Genomics has named Mark Sutherland senior VP of business development. He formerly was VP of genomics at Amersham Biosciences, where he focused on running the DNA sequencing, genotyping, and gene expression business. Sutherland recently was VP of business development at GenVault, and before that he was VP of strategic alliances for GE Healthcare's Discovery Systems Business.

Gen-Probe has named Brian McNamee, who is CEO of the drug company CSL, to re-join the company's board of directors. McNamee already served on the company's board of directors from 2002 to 2007. He has been CEO and managing director of CSL since 1990.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.